Circulating Osteogenic Progenitor Cells Enhanced with Teriparatide or Denosumab Treatment

Circulating osteogenic precursor (COP) cells are peripheral blood cells with a capacity for osteogenesis. The objective of our study was to ascertain the percentage of COPs as an early biomarker of osteoporosis and the effect of these cells in response to Denosumab (DmAb) (anti-resorptive) or to Ter...

Full description

Bibliographic Details
Main Authors: Mercè Giner, María Angeles Vázquez-Gámez, María José Miranda, Jesús Bocio-Nuñez, Francisco Jesús Olmo-Montes, Miguel Angel Rico, Miguel Angel Colmenero, María-José Montoya-García
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/11/16/4749